Literature DB >> 7862272

The value of three-dimensional turbo-FLASH and spin-echo sequences in the detection of pituitary microadenomas following gadolinium administration.

T Stadnik1, J D'Haens, R Luypaert, M Osteaux.   

Abstract

Our purpose was the comparison of T1-weighted spin-echo (SE) and three-dimensional (3D) Turbo-fast low-angle shot (FLASH) (3DTFL) in detection of 14 pituitary microadenomas following intravenous gadolinium (Gd). 3DTFL represents an important improvement in the diagnosis of pituitary microadenomas. In two cases, the site of the tumour was correctly identified only by Gd-enhanced Turbo-FLASH. Nevertheless, in two other cases, the Gd-enhanced 3DTFL gave false negative (FN) results while the T1-weighted SE images enabled correct localisation. Replacement of T1-weighted SE by 3DTFL cannot therefore be advocated and use of both contrast-enhanced sequences offers the highest detection capability for microadenomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862272     DOI: 10.1007/bf00600416

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  10 in total

1.  High-resolution MR imaging of pituitary microadenomas at 1.5 T: experience with Cushing disease.

Authors:  W W Peck; W P Dillon; D Norman; T H Newton; C B Wilson
Journal:  AJR Am J Roentgenol       Date:  1989-01       Impact factor: 3.959

2.  MR imaging of prolactin-secreting microadenomas.

Authors:  K W Pojunas; D L Daniels; A L Williams; V M Haughton
Journal:  AJNR Am J Neuroradiol       Date:  1986 Mar-Apr       Impact factor: 3.825

3.  Comparison of magnetic resonance imaging and computed tomography in the preoperative evaluation of pituitary adenomas.

Authors:  D A Nichols; E R Laws; O W Houser; C F Abboud
Journal:  Neurosurgery       Date:  1988-02       Impact factor: 4.654

4.  Gadolinium-DTPA and MR imaging of pituitary adenoma: a preliminary report.

Authors:  P C Davis; J C Hoffman; J A Malko; G T Tindall; Y Takei; L Avruch; I F Braun
Journal:  AJNR Am J Neuroradiol       Date:  1987 Sep-Oct       Impact factor: 3.825

5.  [Gd-DTPA in the MR diagnosis of pituitary adenomas].

Authors:  E Steiner; D Wimberger; H Imhof; E Knosp; P Hajek
Journal:  Rofo       Date:  1989-03

6.  Pituitary microadenomas: diagnosis with two-and three-dimensional MR imaging at 1.5 T before and after injection of gadolinium.

Authors:  T Stadnik; A Stevenaert; A Beckers; R Luypaert; T Buisseret; M Osteaux
Journal:  Radiology       Date:  1990-08       Impact factor: 11.105

7.  Pituitary adenomas: high-resolution MR imaging at 1.5 T.

Authors:  W Kucharczyk; D O Davis; W M Kelly; G Sze; D Norman; T H Newton
Journal:  Radiology       Date:  1986-12       Impact factor: 11.105

8.  Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland.

Authors:  J L Doppman; J A Frank; A J Dwyer; E H Oldfield; D L Miller; L K Nieman; G P Chrousos; G B Cutler; D L Loriaux
Journal:  J Comput Assist Tomogr       Date:  1988 Sep-Oct       Impact factor: 1.826

9.  Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.

Authors:  A J Dwyer; J A Frank; J L Doppman; E H Oldfield; A M Hickey; G B Cutler; D L Loriaux; T F Schiable
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

10.  1.5-T MR imaging of pituitary microadenomas: technical considerations and CT correlation.

Authors:  M V Kulkarni; K F Lee; C B McArdle; J W Yeakley; F L Haar
Journal:  AJNR Am J Neuroradiol       Date:  1988 Jan-Feb       Impact factor: 3.825

  10 in total
  1 in total

1.  Magnetic resonance imaging of the normal pituitary gland using ultrashort TE (UTE) pulse sequences (REV 1.0).

Authors:  Olivia Portman; Stephen Flemming; Jeremy P D Cox; Desmond G Johnston; Graeme M Bydder
Journal:  Neuroradiology       Date:  2007-11-22       Impact factor: 2.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.